These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Primary localized amyloidosis presenting as diffuse amorphous calcified mass in both orbits: case report. Gonçalves AC; Moritz RB; Monteiro ML Arq Bras Oftalmol; 2011; 74(5):374-6. PubMed ID: 22184002 [TBL] [Abstract][Full Text] [Related]
9. The use of radiotherapy for the treatment of localized orbital amyloidosis. Khaira M; Mutamba A; Meligonis G; Rose GE; Plowman PN; O'Donnell H Orbit; 2008; 27(6):432-7. PubMed ID: 19085298 [TBL] [Abstract][Full Text] [Related]
10. Optic neuropathy in primary orbital amyloidosis. Finlay KR; Rootman J; Dimmick J Can J Ophthalmol; 1980 Oct; 15(4):189-92. PubMed ID: 7437947 [TBL] [Abstract][Full Text] [Related]
11. Periocular and orbital amyloidosis: clinical characteristics, management, and outcome. Leibovitch I; Selva D; Goldberg RA; Sullivan TJ; Saeed P; Davis G; McCann JD; McNab A; Rootman J Ophthalmology; 2006 Sep; 113(9):1657-64. PubMed ID: 16828514 [TBL] [Abstract][Full Text] [Related]
12. Light chain amyloidosis of the lacrimal glands in a patient with chronic dacryoadenitis. Halliday L; Curragh D; McRae S; Selva D Can J Ophthalmol; 2019 Aug; 54(4):e163-e166. PubMed ID: 31358155 [No Abstract] [Full Text] [Related]
13. Orbital and peri-orbital amyloidosis: a report of four cases. Medel Jiménez R; Sánchez España JC; Vasquez LM; Tapia Bahamondes A; Rondón M; Francesc T; Barroso EA Orbit; 2019 Apr; 38(2):148-153. PubMed ID: 29565698 [TBL] [Abstract][Full Text] [Related]